Cost and Effectiveness Comparison of Immediate Colposcopy Versus Human Papillomavirus DNA Testing in Management of Atypical Squamous Cells of Undetermined Significance in Turkish Women |
Kececioglu, Mehmet
(Department of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital)
Seckin, Berna (Department of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital) Baser, Eralp (Department of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital) Togrul, Cihan (Department of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital) Kececioglu, Tugban Seckin (Department of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital) Cicek, Mahmut Nedim (Department of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital) Gungor, Tayfun (Department of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital) |
1 | Solomon D, Schiffman M, Tarone R (2001). Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst, 93, 293-9. DOI ScienceOn |
2 | Solomon D, Schiffman M, Tarone R (2002). Ascus lsil triage study (Alts) conclusions reaffirmed: response to a november 2001 commentary. Obstet Gynecol, 99, 671-4. DOI ScienceOn |
3 | Bosch F X, Manos MM, Munoz N, et al (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (Ibscc) study group. J Natl Cancer Inst, 87, 796-802. DOI ScienceOn |
4 | Brink AA, Snijders PJ, Meijer CJ, et al (2006). Hpv Testing In Cervical Screening. Best Pract Res Clin Obstet Gynaecol, 20, 253-66. DOI ScienceOn |
5 | Cuzick J, Arbyn M, Sankaranarayanan R, et al (2008). Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine, 10, 29-41. |
6 | Cuzick J, Szarewski A, Cubie H, et al (2003). Management of women who test positive for high-risk types of human papillomavirus: The Hart Study. Lancet, 362, 1871-6. DOI ScienceOn |
7 | Gustafsson L, Ponten J, Zack M, et al (1997). International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control, 8, 755-63. DOI ScienceOn |
8 | Kim JJ, Wright TC, Goldie SJ (2002). Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. Jama, 287, 2382-90. DOI ScienceOn |
9 | Kim JJ, Wright TC, Goldie SJ (2005). Cost-effectiveness of human papillomavirus dna testing in The United Kingdom, The Netherlands, France, and Italy. J Natl Cancer Inst, 97, 888-95. DOI ScienceOn |
10 | Kinney WK, Manos MM, Hurley LB, et al (1998). Where's the high-grade cervical neoplasia? the importance of minimally abnormal papanicolaou diagnoses. Obstet Gynecol, 91, 973-6. DOI ScienceOn |
11 | Kulasingam SL, Kim JJ, Lawrence WF, et al (2006). Cost-Effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study. J Natl Cancer Inst, 98, 92-100. DOI ScienceOn |
12 | Manos MM, Kinney WK, Hurley LB, et al (1999). Identifying women with cervical neoplasia: using human papillomavirus dna testing for equivocal papanicolaou results. JAMA, 281, 1605-10. |
13 | Ronco G, Giorgi-Rossi P, Carozzi F, et al (2006). Human papillomavirus testing nd liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol, 7, 547-55. DOI ScienceOn |
14 | Nanda K, Mccrory DC, Myers ER, et al (2000). Accuracy of the papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med, 132, 810-9. DOI ScienceOn |
15 | Naucler P, Ryd W, Tornberg S, et al (2009). Efficacy of hpv dna testing with cytology triage and/or repeat hpv dna testing in primary cervical cancer screening. J Natl Cancer Inst, 101, 88-99. DOI ScienceOn |
16 | Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al (1999). Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet, 354, 20-5. DOI ScienceOn |
17 | Schiffman M and Solomon D (2003). Findings to date from the ascus-lsil triage study (Alts). Arch Pathol Lab Med, 127, 946-9. |
18 | Arbyn M, Buntinx F, Van Ranst M, et al (2004). Virologic versus cytologic triage of women with equivocal pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst, 96, 280-93. DOI ScienceOn |